(2008). [Promoter methylation and expression of Runx3 gene in gastric cancer]. Zhonghua Wei Chang Wai Ke Za Zhi
(2008). A: Enhancer of zeste homologue 2 (EZH2) down-regulates RUNX3 by increasing histone H3 methylation.
(2010). Aberrant gene methylation in the lymph nodes provides a possible marker for diagnosing micrometastasis in gastric cancer. Ann Surg Oncol
(2002). Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell
(2004). Choi JK: Tumor suppressor activity of RUNX3. Oncogene
(2010). Chung IS: Risk factors in malignant transformation of gastric epithelial neoplasia categorized by the revised Vienna classification: endoscopic, pathological, and immunophenotypic features. Gastric Cancer
(2007). Downregulation of the RUNX3 gene by promoter hypermethylation and hemizygous deletion in breast cancer.
(2010). G: Pathobiologic implications of methylation and expression status of Runx3 and CHFR genes in gastric cancer. Med Oncol
(2002). Global cancer statistics,
(1999). Global cancer statistics.
(2008). Helicobacter pylori infection is an independent risk factor for Runx3 methylation in gastric cancer. Oncol Rep
(2010). Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer.
(1999). Interaction and functional cooperation of PEBP2/CBF with Smads. Synergistic induction of the immunoglobulin germline Calpha promoter.
(2004). Ioannidis JP: Meta-analysis of the association of the cathepsin D Ala224Val gene polymorphism with the risk of Alzheimer’s disease: a HuGE gene-disease association review.
(2004). Ito K: Growth regulation of gastric epithelial cells by Runx3. Oncogene
(2006). Ito Y: Analyses of promoter hypermethylation for RUNX3 and other tumor suppressor genes in nasopharyngeal carcinoma. Anticancer Res
(2005). Ito Y: Frequent loss of RUNX3 gene expression in remnant stomach cancer and adjacent mucosa with special reference to topography.
(2002). Ito Y: Inhibition of growth of mouse gastric cancer cells by Runx3, a novel tumor suppressor. Oncogene
(2006). Ito Y: RUNX3 cooperates with FoxO3a to induce apoptosis in gastric cancer cells.
(2009). Ito Y: Runx3 expression in gastrointestinal tract epithelium: resolving the controversy. Oncogene
(2010). Ito Y: RUNX3 is multifunctional in carcinogenesis of multiple solid tumors. Oncogene
(2004). JG: Promoter hypermethylation downregulates RUNX3 gene expression in colorectal cancer cell lines. Oncogene
(2004). Loss of Runx3 function in leukocytes is associated with spontaneously developed colitis and gastric mucosal hyperplasia. Proc Natl Acad Sci USA
(2003). Motoyama T: Age-related methylation of tumor suppressor and tumor-related genes: an analysis of autopsy samples. Oncogene
(2003). Motoyama T: Promoter hypermethylation of tumor suppressor and tumor-related genes in non-small cell lung cancers. Cancer Sci
(2003). Motoyama T: Promoter methylation status of DAP-kinase and RUNX3 genes in neoplastic and non-neoplastic gastric epithelia. Cancer Sci
(2006). Motoyama T: Quantitative assessment of RUNX3 methylation in neoplastic and non-neoplastic gastric epithelia using a DNA microarray. Pathol Int
(2006). Motoyama T: Spreading of methylation within RUNX3 CpG island in gastric cancer. Cancer Sci
(1986). N: Meta-analysis in clinical trials. Control Clin Trials
(2005). Nakao A: RUNX3 promoter region is specifically methylated in poorly-differentiated colorectal cancer. Anticancer Res
(2010). O: BCL2L10 is frequently silenced by promoter hypermethylation in gastric cancer. Oncol Rep
(2009). Q: Frequent inactivation of RUNX3 by promoter hypermethylation and protein mislocalization in oral squamous cell carcinomas.
(2009). QM: Frequent inactivation of RUNX3 by promoter hypermethylation and protein mislocalization in oral squamous cell carcinomas.
(2003). Runx3 knockouts and stomach cancer. EMBO Rep
(2007). Russo A: Aberrant methylation within RUNX3 CpG island associated with the nuclear and mitochondrial microsatellite instability in sporadic gastric cancers. Results of a GOIM (Gruppo Oncologico dell’Italia Meridionale) prospective study. Ann Oncol
(2006). Sukumar S: RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer. Cancer Research
(2011). The Cochrane Collaboration;
(1999). The DNA methylation paradox. Trends Genet
(2002). The Runx3 transcription factor regulates development and survival of TrkC dorsal root ganglia neurons.
(2004). W: Frequent loss of RUNX3 expression by promoter hypermethylation in gastric carcinoma. Pathobiology
(2005). Weterman MA: Exclusion of RUNX3 as a tumour-suppressor gene in early-onset gastric carcinomas. Oncogene
(2009). WH: Comparative analysis of DNA methylation between primary and metastatic gastric carcinoma. Oncol Rep
(2008). WJ: Methylation of the RUNX3 promoter as a potential prognostic marker for bladder tumor.
(2009). WJ: Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions. Hum Pathol
(2005). Xie K: Loss of RUNX3 expression significantly affects the clinical outcome of gastric cancer patients and its restoration causes drastic suppression of tumor growth and metastasis. Cancer Res
(2008). Yoo K: Methylation of the Tumor Suppressor Gene RUNX3 in Human Gastric Carcinoma. Gut Liver